New weight-loss drugs in the works will offer more choices beyond GLP-1 options Wegovy and Zepbound. What to know about ...

The FDA commissioner's effort to shorten the review of drugs favored by the Trump administration is causing alarm across the ...

LISLE, IL, UNITED STATES, January 12, 2026 /EINPresswire.com/ -- OWP Pharmaceuticals today announced commercial product ...

U.S. Naloxone Market: ~$154 million in annual sales and 9.3 million units annuallyCOMMACK, NY, (GLOBE NEWSWIRE) -- SCIENTURE ...

LAKE WALES, Fla. — The FDA proposed a change to a 60-year-old rule that it said will benefit Florida citrus farmers. The rule would change the required minimum amount of dissolved sugar in pasteurized ...

ARLINGTON, MA - January 06, 2026 - PRESSADVANTAGE - Drug testing in Chandler, AZ has shifted from a simple checkbox in ...

Invitation-only working summit convenes FDA, CMS, and industry leaders April 10 in Charlotte, North Carolina. This call ...

The FDA has approved Edwards Lifesciences Corp.’s Sapien M3 transcatheter mitral valve replacement system. The U.S. approval, announced last week, comes eight months after the device received CE Mark ...

The tension between regulatory compliance and antitrust exposure in Orange Book patent listings reached a dramatic inflection point this fall. In late October, Teva Pharmaceuticals agreed to pay $35 ...

Shares in enVVeno Medical Corp. dropped nearly 30% during after hours trading today after the company announced that the FDA had denied an appeal related to its lead product. After the announcement, ...

Teva Pharmaceuticals has agreed to pay $35 million to resolve a major antitrust lawsuit alleging that the company deliberately delayed generic competition for its QVAR asthma inhalers. The proposed ...